Accumulated uremic toxins attenuate bone mechanical properties in rats with chronic kidney disease

Bone

Volumn 57, Issue 2, 2013, Pages 477-483

  Iwasaki, Yoshiko ^a   Kazama, Junichiro James ^b   Yamato, Hideyuki ^c   Shimoda, Hiroshi ^a   Fukagawa, Masafumi ^d  

^a OITA UNIVERSITY OF NURSING AND HEALTH SCIENCES   (Japan)

^b NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

^c KUREHA CORPORATION   (Japan)

^d TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

AST 120; Chronic kidney disease; Storage module; Uremic toxins

Indexed keywords

AST 120; CARBONIC ACID; INDICAN; PENTOSIDINE; UREMIC TOXIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; BONE DENSITY; CHEMICAL COMPOSITION; CHEMICAL MODIFICATION; CHEMICAL PHENOMENA; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORTICAL BONE; CROSS LINKING; CRYSTALLIZATION; ELASTICITY; HIP FRACTURE; INDICAN BLOOD LEVEL; MALE; MORPHOMETRICS; MUSCULOSKELETAL DISEASE; MUSCULOSKELETAL FUNCTION; NONHUMAN; PARTIAL NEPHRECTOMY; PROTEIN BLOOD LEVEL; RAT; SUBSTITUTION REACTION; THYROPARATHYROIDECTOMY; TOXIN ANALYSIS;

AST-120; CHRONIC KIDNEY DISEASE; STORAGE MODULE; UREMIC TOXINS;

ANIMALS; BIOMECHANICAL PHENOMENA; BONE AND BONES; BONE DENSITY; CREATININE; ELASTIC MODULUS; FEMUR; KIDNEY FUNCTION TESTS; LINEAR MODELS; MALE; RATS; RATS, SPRAGUE-DAWLEY; RENAL INSUFFICIENCY, CHRONIC; SPECTRUM ANALYSIS, RAMAN; UREMIA;

EID: 84886721361     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2013.07.037     Document Type: Article

References (35)

1. Trombetti A., Herrmann F., Hoffmeyer P., Schurch M.A., Bonjour J.P., Rizzoli R. Survival and potential years of life lost after hip fracture in men and age-matched women. Osteoporos Int 2002, 13:731-737.
2. Haentjens P., Magaziner J., Colón-Emeric C.S., Vanderschueren D., Milisen K., Velkeniers B., et al. Meta-analysis: excess mortality after hip fracture among older women and men. Ann Intern Med 2010, 152:380-390.
3. Mittalhenkle A., Gillen D.L., Stehman-Breen C.O. Increased risk of mortality associated with hip fracture in the dialysis population. Am J Kidney Dis 2004, 44:672-679.
4. Alem A.M., Sherrard D.J., DL Gillen, Weiss N.S., Beresford S.A., Heckbert S.R., et al. Increased risk of hip fracture among patients with end-stage renal disease 2000, 58:396-399.
5. Wakasugi M., Kazama J.J., Taniguchi M., Wada A., Iseki K., Tsubakihara Y., et al. Increased risk of hip fracture in Japanese hemodialysis patients. J Bone Miner Metab 2013, 31:315-321.
6. Jadoul M., Albert J.M., Akiba T., Akizawa T., Arab L., Bragg-Gresham J.L., et al. Incidence and risk factors for hip or other bone fracture among hemodialysis patients in the dialysis outcomes and practice patterns study. Kidney Int 2006, 70:1358-1366.
7. Dooley A.C., Weiss N.S., Kestenbaum B. Increased risk of hip fracture among men with CKD. Am J Kidney Dis 2008, 51:38-44.
8. Fried L.F., Biggs M.L., Shlipak M.G., Shlipak M.G., Seliger S., Kestenbaum B., et al. Association of kidney function with incident hip fracture in older adults. J Am Soc Nephrol 2007, 18:282-286.
9. Lindberg J.S., Moe S.M. Osteoporosis in end-stage renal disease. Semin Nephrol 1999, 19:115-122.
10. Jamal S.A., Hayden J.A., Beyene J. Low bone mineral density and fractures in long-term hemodialysis patients: a meta-analysis. Am J Kidney Dis 2007, 49:674-681.
11. Yenchek R.H., Ix J.H., Shlipak M.G., Bauer D.C., Rianon N.J., Kritchevsky S.B., et al. Health, aging, and body composition study. Bone mineral density and fracture risk in older individuals with CKD. Clin J Am Soc Nephrol 2012, 7:1130-1136.
12. Jamal S.A., Leiter R.E., Jassal V., Hamilton C.J., Bauer D.C. Impaired muscle strength is associated with fracture in hemodialysis patients. Osteoporos Int 2006, 17:1390-1397.
13. Danese M.D., Kim J., Doan Q.V., Dylan M., Griffiths R., Chertow G.M. PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis. Am J Kidney Dis 2006, 47:149-156.
14. Nakai S., Suzuki K., Masakane I., Wada A., Itami N., Ogata S., et al. Overview of regular dialysis treatment in Japan (as of 31 December 2008). Ther Apher Dial 2010, 14:505-540.
15. Iwasaki Y., Kazama J.J., Yamato H., Yamato H., Fukagawa M. Changes in chemical composition of cortical bone associated with bone fragility in rat model with chronic kidney disease. Bone 2011, 48:1260-1267.
16. Iwasaki Y., Yamato H., Nii-Kono T., Nii-Kono T., Fujieda A., Uchida M., et al. Administration of oral charcoal adsorbent (AST-120) suppresses low-bone progression in uremic rats. Nephrol Dial Transplant 2006, 21:2768-2774.
17. Malluche H.H., Porter D.S., Monier-Faugere M.C., Mawad H., Pienkowski D. Differences in bone quality in low-and high-turnover renal osteodystrophy. J Am Soc Nephrol 2012, 23:525-532.
18. Parfitt A.M., Drezner M.K., Glorieux F.H., Kanis J.A., Malluche H., Meunier P.J., et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR histomorphometry Nomenclature Committee. J Bone Miner Res 1987, 2:595-610.
19. Menard K.P. Dynamic mechanical analysis: a practical introduction 2008, 1-15. CRC Press, New York.
20. Vashishth D. The role of the collagen matrix in skeletal fragility. Curr Osteoporos Rep 2007, 5:62-66.
21. Viguet-Carrin S., Roux J.P., Arlot M.E., Merabet Z., Leeming D.J., Byrjalsen I., et al. Contribution of the advanced glycation end product pentosidine and of maturation of type I collagen to compressive biomechanical properties of human lumbar vertebrae. Bone 2006, 39:1073-1079.
22. Carden A., Rajachar R.M., Morris M.D., Kohn D.H. Ultrastructural changes accompanying the mechanical deformation of bone tissue: a Raman imaging study. Calcif Tissue Int 2003, 72:166-175.
23. Saito M., Marumo K. Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus. Osteoporos Int 2010, 21:195-214.
24. Paschalis E.P., Shane E., Lyritis G., Skarantavos G., Mendelsohn R., Boskey A.L. Bone fragility and collagen cross-links. J Bone Miner Res 2004, 19:2000-2004.
25. Saito M., Marumo K., Kida Y., Ushiku C., Kato S., Takao-Kawabata R., et al. Changes in the contents of enzymatic immature, mature, and non-enzymatic senescent cross-links of collagen after once-weekly treatment with human parathyroid hormone (1-34) for 18months contribute to improvement of bone strength in ovariectomized monkeys. Osteoporos Int 2011, 22:2373-2383.
26. Hernandez C.J., Tang S.Y., Baumbach B.M., Hwu P.B., Sakkee A.N., van der Ham F., et al. Trabecular microfracture and influence of pyridinium and non-enzymatic glycation-mediated collagen cross-links. Bone 2005, 37:825-832.
27. Miyata T., Wada Y., Cai Z., Iida Y., Horie K., Yasuda Y., et al. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. Kidney Int 1997, 51:1170-1181.
28. Gourion-Arsiquaud S., Lukashova L., Power J., Loveridge N., Reeve J., Boskey A.L. Use of FTIR spectroscopic imaging to identify parameters associated with fragility fracture. J Bone Miner Res 2009, 24:1565-1571.
29. Akkus O., Adar F., Shaffler M.B. Age-related changes in physicochemical properties of mineral crystals are related to impaired mechanical function of cortical bone. Bone 2004, 34:443-453.
30. Yerramshetty J.S., Lind C., Akkus O. The compositional and physicochemical homogeneity of male femoral cortex increases after the sixth decade. Bone 2006, 29:1236-1243.
31. Akkus O., Polyakova-Akkus A., Adar F., Schaffler M.B. Aging of microstructural compartments in human compact bone. J Bone Miner Res 2003, 18:1012-1019.
32. Niwa T., Nomura T., Sugiyama S., Miyazaki T., Tsukushi S., Tsutsui S. The protein metabolite hypothesis, a model for the progression of renal failure: an oral adsorbent lowers indoxyl sulfate levels in undialyzed uremic patients. Kidney Int 1997, 62:S23-S28.
33. Goto S., Yoshiya K., Kita T., Fujii H., Fukagawa M. Uremic toxins and oral adsorbents. Ther Apher Dial 2011, 15:132-134.
34. Kikuchi K., Itoh Y., Tateoka R., Ezawa A., Murakami K., Niwa T. Metabolomic search for uremic toxins as indicators of the effect of an oral sorbent AST-120 by liquid chromatography/tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2010, 878:2997-3002.
35. Nakagawa N., Hasebe H., Nakagawa N., Hasebe N., Sumitomo K., Fujino T., et al. An oral adsorbent, AST-120, suppresses oxidative stress in uremic rats. Am J Nephrol 2006, 26:455-461.